Engaging the Innate and Adaptive Antitumor Immune Response in Lymphoma

Immunotherapy has emerged as a powerful therapeutic strategy for many malignancies, including lymphoma. As in solid tumors, early clinical trials have revealed that immunotherapy is not equally efficacious across all lymphoma subtypes. For example, immune checkpoint inhibition has a higher overall r...

Descripción completa

Detalles Bibliográficos
Autores principales: Csizmar, Clifford M., Ansell, Stephen M.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2021
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8038124/
https://www.ncbi.nlm.nih.gov/pubmed/33804869
http://dx.doi.org/10.3390/ijms22073302

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8038124/
https://www.ncbi.nlm.nih.gov/pubmed/33804869
http://dx.doi.org/10.3390/ijms22073302

Ejemplares similares